← Back to Search

Audio recording and instructional flashcard with tourniquet ("audio kit") - 6 month follow-up for Bleeding (SLAPS Trial)

N/A

Waitlist Available

Led By Peter Delaney

Research Sponsored by University of Michigan

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 6 months

Awards & highlights

SLAPS Trial Summary

This trial tested if point-of-care instructions are as effective as in-person training for bleeding control.

Eligible Conditions

Bleeding
Cuts

SLAPS Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 6 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~6 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Correct tourniquet application at 6-month follow-up

Correct tourniquet application at initial encounter

Secondary outcome measures

Level of Participant Confidence at 6-month follow-up

Level of Participant Confidence initially

SLAPS Trial Design

4Treatment groups

Experimental Treatment

Active Control

Group I: Instructional flashcard with tourniquet - 6 month follow-upExperimental Treatment1 Intervention

Instructional flashcard with pictures corresponding to each of the 6 steps of tourniquet application, used for tourniquet application attempt. Participants repeat the tourniquet application attempt with the instructional flashcard at 6 month follow-up

Group II: In-person training with tourniquet - 6 month follow-upExperimental Treatment1 Intervention

Stop the Bleed bleeding control (B-Con) course is used for instruction for tourniquet application attempt. Participants repeat the tourniquet application attempt without any POC instruction or re-training at 6 month follow-up

Group III: Audio recording and instructional flashcard with tourniquet ("audio kit") - 6 month follow-upExperimental Treatment1 Intervention

MP3 audio files for each of 6 steps and instructional flashcard with pictures corresponding to each of the 6 steps of tourniquet application, used for tourniquet application attempt. Participants repeat the tourniquet application attempt with the audio kit at 6 month follow-up

Group IV: Control group with no in-person training and no point-of-care instruction access - 6 month follow-upActive Control1 Intervention

There is no in-person training or point-of-care (POC) instructional interventions for this group for tourniquet application attempt. Participants repeat the tourniquet application attempt without any in-person training or POC instructional interventions at 6 month follow-up

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Audio kit

2022

N/A

~470

Instructional flashcard

2023

N/A

~210

In-person training

2022

N/A

~470

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Washington University School of MedicineOTHER

1,931 Previous Clinical Trials

2,299,504 Total Patients Enrolled

3 Trials studying Bleeding

214 Patients Enrolled for Bleeding

University of MichiganLead Sponsor

1,795 Previous Clinical Trials

6,373,731 Total Patients Enrolled

1 Trials studying Bleeding

80 Patients Enrolled for Bleeding

LFR InternationalUNKNOWN

2 Previous Clinical Trials

1,465 Total Patients Enrolled

Media Library

In-person training Clinical Trial Eligibility Overview. Trial Name: NCT05812352 — N/A

Bleeding Research Study Groups: Control group with no in-person training and no point-of-care instruction access - 6 month follow-up, Audio recording and instructional flashcard with tourniquet ("audio kit") - 6 month follow-up, Instructional flashcard with tourniquet - 6 month follow-up, In-person training with tourniquet - 6 month follow-up

Bleeding Clinical Trial 2023: In-person training Highlights & Side Effects. Trial Name: NCT05812352 — N/A

In-person training 2023 Treatment Timeline for Medical Study. Trial Name: NCT05812352 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are applicants below the age of sixty admissible to this research project?

"Eligibility for participation in this trial is limited to patients aged 18-99. Furthermore, there are 56 studies specifically for minors and 301 research initiatives targeted at individuals over the age of 65 years old."

Answered by AI

Does this trial have open enrollment?

"Affirmative. According to clinicaltrials.gov, this particular study is actively seeking volunteers as of April 11th 2023 - the date on which it was most recently updated. The trial began registration on January 24th and requires 280 participants from 1 site."

Answered by AI

Could I be enrolled in this experiment?

"In order to qualify for this clinical trial, potential participants must present with bleeding and be between 18-99 years of age. This investigation is currently looking towards recruiting approximately 280 individuals."

Answered by AI

What is the sample size of this research endeavor?

"Affirmative. Clinicaltrials.gov displays that this investigation is currently recruiting patients, with the first posting having been on January 24th 2023 and updated lastly April 11th 2023. This trial requires 280 participants from one location to complete it successfully."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Supporting Laypeople Addressing Prehospital Hemorrhage Study

Zachary Eisner 2023. "Supporting Laypeople Addressing Prehospital Hemorrhage Study". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05812352.